Trial Profile
A Phase 1, Randomized, Single-Dose, 3-Way, Crossover Study to Compare the Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of AVP-923 (Dextromethorphan Hydrobromide and Quinidine Sulfate Capsules) Administered in Applesauce or Via a Nasogastric Feeding Tube With Administration of a Capsule in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Dextromethorphan/quinidine (Primary)
- Indications Agitation; Drug-induced dyskinesia; Emotional lability; Migraine
- Focus Pharmacokinetics
- Sponsors Avanir Pharmaceuticals
- 21 Feb 2018 Status changed from recruiting to completed.
- 02 Jan 2018 New trial record